glp-1 long-term effects drugs calm inflammation beyond diabetes and weight loss Psychological and behavioral effects of

A 2025 network meta-analysis ranked nausea risk as follows: orforglipron (highest, relative risk 4.77), liraglutide (3.09), semaglutide (2.94), tirzepatide (2.89), exenatide (2.66), and cagrilintide (2.29)

Some patients continue on low-dose maintenance therapy

blue: male-specific PTs), revealing distinct gender-based patterns

Subcutaneous weekly semaglutide with automated insulin delivery in type 1 diabetes: a double-blind, randomized, crossover trial

It is not yet possible to conclude whether the elevation in pAMPK levels causes harm to dopaminergic neurons or can promote neuronal survival [131]

doi: 10.1111/apha.12646